Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Debt / NOTE 1.000% 9/1
-
Number of holders
-
10
-
Total 13F principal, excl. options
-
225,526,000
-
Principal change
-
-4,053,000
-
Total reported value, excl. options
-
$126,796,674
-
Value change
-
-$2,293,110
-
Number of buys
-
1
-
Number of sells
-
2
-
Price
-
$0.5647
Institutional Holders of CARDLYTICS INC - NOTE 1.000% 9/1 as of Q2 2023
As of 30 Jun 2023 CARDLYTICS INC - NOTE 1.000% 9/1 had 10 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $225,526,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included CITADEL ADVISORS LLC, Linden Advisors LP, WOLVERINE ASSET MANAGEMENT LLC, CAPSTONE INVESTMENT ADVISORS, LLC, 683 Capital Management, LLC, Royal Bank of Canada, GABELLI FUNDS LLC, WELLINGTON MANAGEMENT GROUP LLP, Teton Advisors, Inc., and GAMCO INVESTORS, INC. ET AL.
This table shows 10 bond principal holders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.